Performance of The Asthma Clinical Score and The Pediatric Respiratory Assessment Measure in Obese Children Presenting to The Emergency Department for Asthma Exacerbations
The study compared the Asthma Clinical Score (ACS) and PRAM for assessing asthma severity in children, including those with obesity. ACS was more reliable and better predicted hospitalization, while PRAM performed less well in obese children. Clinical implications: ACS may be preferred for guiding treatment in pediatric asthma, especially in obese patients. Also, clinicians should consider patient characteristics when interpreting severity scores, as tools may perform differently across subgroups. Full Access: Journal of Asthma
Teenage Girl’s Case Highlights Potential Explanation for Chronic UTIs
The article describes a case of recurrent urinary tract infections that were ultimately linked to E. coli bacteria embedded deep within the bladder wall, where they can evade antibiotics and immune clearance. This case supports emerging evidence that some chronic UTIs are not due to repeated reinfections but rather persistent intracellular bacterial reservoirs that trigger recurring symptoms once antibiotics stop. The finding may help explain why standard prolonged or repeated antibiotic courses often fail in certain pediatric and adolescent patients. Clinical implications: Clinicians should consider alternative mechanisms, such as intracellular bacterial persistence, in patients with recurrent UTIs despite appropriate therapy. These insights highlight the need for new diagnostic approaches and targeted treatments beyond conventional antibiotics to manage chronic or refractory UTIs. Full Access: HealthDay
New Vaccine Schedule Adds Near- and Long -Term Risks for Children, Experts Warn
Recent changes to the childhood vaccine schedule shift several vaccines from routine recommendation to shared clinical decision-making, which experts warn could increase both short- and long-term risks for children by reducing overall immunization coverage. Critics argue the revisions were not supported by strong new scientific evidence and may lead to confusion, lower uptake, and resurgence of preventable infectious diseases. Clinical implications: Clinicians may need to spend more time counseling families and addressing uncertainty as vaccine decisions become more individualized rather than standardized. There is also concern that decreased vaccination rates could result in higher rates of illness, hospitalizations, and outbreaks, requiring closer surveillance and public health response. Full Access: STAT
Clinical Practice Guideline Update by the Infectious Diseases Society of America on Group A Streptococcal (GAS) Pharyngitis
The 2025 IDSA guideline update emphasizes better risk assessment for patients with sore throat by suggesting the use of clinical scoring systems (e.g., Centor or McIsaac) to determine who should be tested for GAS pharyngitis rather than relying solely on clinician judgment, since most sore throats are viral and do not benefit from antibiotics. The guideline notes that scoring can help identify low-risk patients who may not need diagnostic testing, reducing unnecessary costs and antibiotic use, and that high-risk individuals (e.g., household GAS exposure or history of rheumatic fever) should still be tested regardless of score. Clinical implications: Incorporating scoring systems into practice may improve antimicrobial stewardship by limiting unnecessary antibiotic prescriptions and supporting more standardized decision-making. Additionally, clinicians should continue to combine scoring with consideration of individual risk factors and local epidemiology to guide testing and treatment, particularly in children and adults presenting with pharyngitis. Full Access: IDSA